Patent · US Active

Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof

US7635693B2 · kind B2 · utility

2Cited by
5References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2006
Grant dateDec 22, 2009
Priority date
Expiry dateSep 11, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D205/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The subject invention concerns N-thiolated β-lactam compounds of formula A,wherein R1 is a hydrocarbon group having 1-8 carbon atoms; R3 is an organothio group; and R4 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, cycloalkenyl, or heterocycloalkenyl, and analogs and pharmaceutically acceptable salts, esters and amides thereof. The subject invention also concerns methods for inducing tumor cell death or inhibiting tumor cell proliferation, and methods for inducing DNA damage, inhibiting DNA replication, activating p38 MAP kinase, or activating caspase cascade activation, or releasing cytochrome C from mitochondria into the cytoplasm in a tumor cell. Methods for treating cancer using N-thiolated β-lactam compounds, as well as pharmaceutical compositions comprising the same are further disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.